Le Lézard
Classified in: Business
Subjects: EARNINGS, Annual Meeting, Business Update

Berkshire Hathaway Inc. News Release


Berkshire Hathaway Inc.'s 2023 Annual Report to the shareholders will be posted on the Internet on Saturday, February 24, 2024, at approximately 8:00 a.m. eastern time where it can be accessed at www.berkshirehathaway.com. Concurrent with the posting of the Annual Report, Berkshire will also issue an earnings release.

The Annual Report will include Warren Buffett's annual letter to shareholders as well as information about Berkshire's financial position and results of operations. The Annual Report will also include information regarding Berkshire's Shareholders Meeting to be held on Saturday, May 4, 2024 and related events.

Berkshire Hathaway and its subsidiaries engage in diverse business activities including insurance and reinsurance, utilities and energy, freight rail transportation, manufacturing, retailing and services. Common stock of the company is listed on the New York Stock Exchange, trading symbols BRK.A and BRK.B.


These press releases may also interest you

at 03:40
HTA Group, Ltd (the "Offeror"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the launch of its offer to purchase for cash any and all of the 7.000% Senior...

at 03:20
In a grand ceremony held on Wednesday in the Russian Embassy in Beijing, two sculptures portraying the renowned Russian novelist Maxim Gorky (1868-1936) and his Chinese counterpart Lu Xun (1881-1936), who was the most influential representative of...

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 03:00
KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today released its report on cyber threats faced by the financial sector in the UK. The report examines the escalating rise of cyberattacks on...

at 02:46
OKX, a leading Web3 technology company, has issued updates for May 20, 2024. OKX DEX Incorporates ChangeNOW's Cross-Chain Bridges:...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: